ipriflavone has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pagano, L | 1 |
| Teofili, L | 1 |
| Mele, L | 1 |
| Piantelli, M | 1 |
| Ranelletti, FO | 1 |
| Equitani, F | 1 |
| Larocca, LM | 1 |
| Leone, G | 1 |
1 trial available for ipriflavone and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Oral ipriflavone (7-isopropoxy-isoflavone) treatment for elderly patients with resistant acute leukemias.
Topics: Administration, Oral; Aged; Drug Resistance, Neoplasm; Female; Humans; Isoflavones; Leukemia, Myeloi | 1999 |